Publication

Article

Pharmaceutical Technology

Pharmaceutical Technology-09-02-2014
Volume38
Issue 9

Thermo Fisher Scientific UHPLC System Improves Productivity

Thermo Fisher Scientific's Vanquish ultra-high performance liquid chromatography (UHPLC) system is a new design for improved productivity and usability when used as a standalone system or with the latest mass spectrometers.

Thermo Fisher Scientific’s Vanquish ultra-high performance liquid chromatography (UHPLC) system is a new design for improved productivity and usability when used as a standalone system or with the latest mass spectrometers.

The system uses the new Thermo Scientific Accucore Vanquish UHPLC column with Core Enhanced Technology. SmartFlow pumping technology allows reproducible retention times and low baseline noise to enhance detection sensitivity. Temperature control capabilities, including direct heating and forced air temperature control modules in the column compartment, enhance separation efficiency and selectivity and retention time reproducibility. An insulated autosampler compartment with new air-to-air cooling protects vials from water condensation, even in hot and humid environments.

ref="http://www.thermofisher.com/vanquish" target="_blank" ref="nofollow">Thermo Fisher Scientific

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
Simona Guidi, Associate Director, ProPharma
Tore Bergsteiner
Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More
Related Content